Engineered Veterinary Vectored Immunotherapy and Vaccines: EVVIVAX

Just open a Bet365 account today and make a deposit Make a deposit of £10-£200 and then enter the 10-digit bonus code


  • In vivo electro-gene-transfer of plasmid DNA (DNA-EGT) allows gene therapy and vaccine applications. In addition to the increased gene expression, EGT enhances immune responses through an adjuvant effect induced by the procedure. As a result, both antigen-specific humoral and cellular immune responses from EGT mediated delivery of plasmid DNA are higher than levels achieved by intramuscular injection of DNA alone.

  • EVVIVAX capitalizes on more than 15 years experience spent setting up and perfectioning DNA-EGT.

Tech Electro Gene Transfer

Evvivax News

  • 10-12 Apr 2017

    10-12 Apr 2017 - EVVIVAX at the World Veterinary Vaccine Conference, Washington DC, USA Join us at t...
  • 7 Apr 2017

    7 Apr 2017: EVVIVAX Visiting PennVet, Philadelphia, USA Dr Luigi Aurisicchio, CEO at EVVIVAX and Pre...
  • 10-12 Oct 2016

    Barcelona, 10-12 October 2016: EVVIVAX will be at the World Veterinary Vaccine Meeting
  • 6 Sep 2016

    London, 6 September 2016:EVVIVAX has participated at the meeting "Comparative Oncology: The Next Fro...